Oaktree Acquisition Corp. III Life Sciences (OACC)

Market Cap	263.04M +2.5%
Revenue (ttm)	n/a
Net Income	7.02M
EPS	0.29
Shares Out	24.58M
PE Ratio	37.45
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	56
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	10.30 - 10.74
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About OACC

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.

• Industry: Shell Companies
• Sector: Financials
• IPO Date: Oct 24, 2024
• Country: United States
• Stock Exchange: NASDAQ
• Ticker Symbol: OACC

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Jul 18, 2026

Data Sources Report a data error